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Transplantation and Its Correlation with Delayed 
graft Function 
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Farhad gholami,1 Mahmoud Mohebbi,1 Abbas Ali Zeraati,3 Hassan Ahmadnia,4  
Hamid Tabarraiei,5 Mahsa Baradaran,1 Mohammad Javad Mojahedi1
Introduction: Thyroid hormones affect kidney function and may alter with 
changes in kidney function, as well. We evaluated changes in serum levels 
of triiodothyronine (T3), thyroxin (T4), and thyroid-stimulating hormone 
(TSH) early after kidney transplantation and their relationship with delayed 
graft function (DGF).
Materials and Methods: Fifty-five consecutive kidney allograft recipients 
were enrolled in the study. Serum levels of T3, T4, and TSH were measured 
on the day before transplantation, and also on posttransplant days 1, 3, 7, 
14, and 21. Results were compared between patients with a normal allograft 
function and those with DGF. 
Results: The mean T3 level decreased from 110.41 ± 49.79 ng/dL before 
transplantation to 80.78 ± 51.42 ng/dL on the 1st day after transplantation 
(P = .04), while T4 reduction reached a significant level on the 3rd day after 
transplantation (8.27 ± 3.27µg/dL to 5.50 ± 2.57 µg/dL, P = .004). Patients 
with DGF experienced a significantly greater decrease in the serum level of T3 
at the end of the 1st week after transplantation compared with patients with 
normal kidney function (P = .02). This significant decrease in T3 continued 
until the end of the 2nd week. Serum levels of T4 reduced comparably in 
the two groups, until the end of the 1st week, when it showed a significantly 
more reduction in the patients with DGF (P = .04).
Conclusion: Both T3 and T4 reduced early after kidney transplantation, 
and this reduction was significantly more prominent in those with DGF. 
This is compatible with a consequence rather than a cause of DGF, explained 
in the setting of sick euthyroid syndrome.
Urol J. 2010;7:30-4. 
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INTRODUCTION
Thyroid hormones affect the 
functions of a number of organs, 
and these may alter the kidney 
function, as well. On the other 
hand, the thyroid gland function 
may be influenced by kidney 
dysfunction.(1-3) Patients with 
end-stage renal disease may suffer 
from elevated thyroid-stimulating 
hormone (TSH) levels, reduced 
TSH response to thyroid-releasing 
hormone, and reduced serum 
total and free triiodothyronine 
(T3) and thyroxine (T4) values, 
in the absence of a primary 
thyroid disease.(1,2) Then again, 
these patients may develop 
goiter, thyroid nodules, thyroid 
carcinoma, and hypothyroidism. (2) 
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Kidney transplantation alleviates these changes, 
but it can also affect thyroid function in the 
presence of different conditions a kidney 
transplant recipient may experience.(4) 
In this study, we evaluated T3, T4, and TSH 
changes early after kidney transplantation, 
and the relationship of these changes with the 
occurrence of delayed graft function (DGF). In 
hope of finding a correlation between DGF and 
thyroid hormone changes measured by routine 
and simple thyroid function assessment tests 
available in all laboratories, we purposefully 
decided not to perform more complicated thyroid 
function tests such as reverse T3 and T3 resin 
uptake.
MATERIALS AND METHODS 
Fifty-five kidney transplant candidates were 
consecutively selected to enroll in this cross-
sectional study. Thirty-seven patients were living 
donor allograft recipients and the remaining 
18 received a cadaveric kidney graft. The study 
was approved by the ethics committee of the 
university and the patients provided informed 
consent.
Before transplantation, all of the patients were 
on hemodialysis. Immunosuppression after 
transplantation consisted of cyclosporine, 
mycophenolate mofetil, and prednisone. Serum 
levels of T3, T4, and TSH were measured on 
the day before transplantation, and also on 
the 1st and 3rd days and at the end of the 1st, 
2nd, and 3rd weeks after transplantation, using 
radioimmunoassay method. In search of the 
relationship between kidney allograft function 
and thyroid hormone changes, serum levels of T3, 
T4, and TSH on the day before transplantation 
(baseline) were compared with each consequent 
posttransplant measurement in all patients. Also, 
T3, T4, and TSH levels were compared between 
patients with normal immediate kidney function 
and those with DGF. Delayed graft function was 
defined as a decrease in the serum creatinine level 
of at least 10% per day for at least 3 consecutive 
days during the first week after transplantation. 
We used the paired t test for comparisons of the 
T3 and T4 levels in patients with and without 
DGF in each subsequent measurement in relation 
with before transplantation. Due to non-normal 
distribution of TSH serum levels, the Mann 
Whitney U test and the Wilcoxon sum rank test 
were used for comparing its serum level in the 
two groups and its changes in each measurement 
after transplantation in comparison with those 
before transplantation, respectively. General 
linear model repeated measurement analysis was 
used for overall significance of T3, T4, and TSH 
changes in the six measurements. 
RESULTS
A total of 55 kidney recipients (34 men and 
21 women), with a mean age of 34.41 ± 15.47 
years, were included in the study. The kidney 
allograft resumed normal function in 47 patients 
(85.5%), while in 8 patients (14.5%), its function 
was delayed due to acute rejection in 2 and acute 
tubular necrosis (ATN) in 6. Baseline thyroid 
function studies, including serum levels of T3, T4, 
and TSH, were similar between the two groups of 
patients with normal graft function and DGF.
Repeated measurement analysis showed highly 
significant changes in T3, T4, and TSH through 
the 6 measurements (P < .001). The mean T3 
level decreased from 110.41 ± 49.79 ng/dL on the 
day before transplantation to 80.78 ± 51.42 ng/dL 
on the 1st day after transplantation (P = .04). This 
trend continued until the end of the 2nd week 
after transplantation. Serum level of T4 decreased 
from 8.27 ± 3.27µg/dL before transplantation 
to 6.92 ± 3.72 µg/dL on the 1st posttransplant 
day (P = .09). This trend in T4 concentrations 
reached a significant level on the 3rd day after 
transplantation (4.55 ± 2.57 µg/dL, P = .004); 
however, T4 levels reached the pretransplant levels 
at the end of the 3rd week after transplantation. 
Patients with DGF experienced a significantly 
greater decrease in the serum level of T3 at 
the end of the 1st week after transplantation 
compared with patients with normal kidney 
function (P = .02; Table 1). This significant 
decrease in T3 continued until the end of the 2nd 
week. Serum levels of T4 reduced comparably 
in the two groups, until the end of the 1st week, 
when it showed a significantly more reduction in 
the patients with DGF (Table 1). 
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Serum levels of TSH began to decrease 
significantly from the 1st day after transplantation 
compared with the baseline values (P < .001; 
Table 2). This trend continued to the end of 
the 3rd week after transplantation when serum 
TSH level returned to the pretransplantation 
level. Comparing TSH levels in patients with 
and without DGF, TSH levels decreased on the 
1st day after transplantation in both groups, but 
significantly reduced TSH level continued until 
the end of the 3rd week after transplantation 
only in the kidney allograft recipients with 
normal kidney function, but returned to normal 
in the patients with DGF on the 3rd day after 
transplantation (Table 3). 
We compared serum TSH levels between the 
patients who received antithymocyte globulin 
(ATG) and those with no ATG administration; 
The significant reduction of TSH level in those 
with ATG continued to the end of the 3rd week, 
while in patients who received ATG, TSH 
returned to the pretransplantation levels after 1 
week. There were no associations between donor 
source, age, gender, and the underlying disease 
and the thyroid hormones before transplantation 
and their changes after transplantation.
DISCUSSION 
Our finding, the moderate reduction of serum 
T3 and T4 levels on the 1st and 3rd days after 
transplantation, is compatible with sick euthyroid 
syndrome (SES). Due to the rather shorter T3 
half-life in comparison with the half-life of T4, 
reduction of T3 began earlier than T4.(3) Using 
the same way of reasoning, earlier return of 
T3 serum level (at the end of the 1st week) 
compared with T4 can be explained. In the SES 
(low serum levels of T3, T4, TSH, or all the 
three), high endogenous catecholamine levels 
may stimulate preferential tissue conversion of 
T4 to the nonactive reverse T3 rather than to 
the active free T3.(4) Plasma T3 levels, therefore, 
drop precipitously. There is evidence that low T3 
states occur immediately after kidney transplant 
due to the stress of the operation, infusion of 
high-dose intravenous methylprednisolone, and 
hypothermia. The continuation of significantly 
reduced T3 in patients with DGF into the second 
week after transplantation may be regarded as 
a cause or consequent of failed graft function; 
regarding the nonsignificant difference in T3 
serum level between the two groups before 
transplantation, we hypothesize that DGF leads 
to continuation of uremic state, administration 
of higher doses of methylprednisolone, more 
severe reperfusion injury, and inflammation, all 
impairing conversion of T4 to T3. 
Delayed Graft Function
Laboratory Study No Yes P
T3, ng/dL
Baseline 106.2 ± 40.85 121.62 ± 30.99 .33
Day 1 90.64 ± 41.64 85.00 ± 43.49 .71
Day 3 86.53 ± 35.06 83.05 ± 21.09 .77
Day 7 85.18 ± 35.39 57.90 ± 15.86 .02
Day 14 82.54 ± 26.44 78.75 ± 23.81 .67
Day 21 91.13 ± 28.79 93.79 ± 34.57 .81
T4, µg/dL
Baseline 8.36 ± 3.06 8.55 ± 3.25 .88
Day 1 7.68 ± 2.84 7.24 ± 3.75 .68
Day 3 6.80 ± 2.94 5.49 ± 1.90 .16
Day 7 6.41 ± 2.32 4.69 ± 2.86 .04
Day 14 6.54 ± 2.28 5.03 ± 1.13 .04
Day 21 7.88 ± 3.35 6.56 ± 2.72 .23
Table 1. Changes in Triiodothyronine (T3) and Thyroxin (T4) 
After Kidney Transplantation in Recipients With and Without 
Delayed graft Function
TSH Measurement TSH, IU/mL P*
Baseline 1.94 ± 0.89 …
Day 1 1.09 ± 0.76 < .001
Day 3 0.95 ± 0.90 < .001
Day 7 1.04 ± 0.79 .01
Day 14 1.86 ± 2.89 .02
Day 21 1.78 ± 0.40 .15
Table 2. Thyroid-Stimulating Hormone (TSH) Levels Before and 
After Transplantation
*P values are related to the comparisons between TSH level of that 
measurement (the respective row) with the previous one.
Normal Kidney 
Function
Delayed Graft 
Function
TSH 
Measurement
Mean Change, 
IU/mL P
Mean Change, 
IU/mL P
Day 1 -3.18 .001 -2.11 .04
Day 3 -4.17 < .001 -1.76 .08
Day 7 -3.97 < .001 -0.94 .35
Day 14 -2.28 .02 -0.92 .36
Day 21 -2.96 .003 -0.54 .59
Table 3. Changes in Serum Thyroid-Stimulating Hormone 
(TSH) Levels Compared to Baseline Level Before Kidney 
Transplantation in Recipients With and Without Delayed graft 
Function
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Lebkowska and colleagues found that the free 
T3 concentration correlated with function of 
the kidney allograft.(6) They suggested that in 
transplant patients, the supplementary thyroid 
hormone therapy should be considered.(6) In 
another study, a positive correlation was found 
between changes in serum concentration of free 
T4 and changes in serum creatinine (r = 0.73; 
P < .001).(7) Reinhardt and colleagues showed 
that T3 concentrations reflected kidney allograft 
function after kidney transplantation. Serum 
T3 was below the normal limit in patients with 
DGF (acute kidney failure or acute rejection). 
The postoperative period (up to 3 days after 
transplantation) was associated with a low T3 
syndrome. Thyroid-stimulating hormone did 
not return to the pre-operative values, even in 
patients with primary graft function.(8) Recovery 
in the hormonal status did not start in the first 
week of posttransplant period. A significant 
transient decrease in TSH, free T3, and free T4 
concentrations following kidney transplantation 
has been reported in kidney allograft recipients. (9) 
However, comparing thyroid hormone changes 
in donors and recipients immediately after 
transplantation, T3 changes observed in donors 
and recipients were similar, indicating that the 
hormonal changes observed are mostly due to 
surgical stress.(10) 
In our study, acute tubular necrosis was the 
prevalent cause of DGF (in 6 cases). Regarding 
TSH serum level changes, reduced TSH level 
continued until the end of the 3rd week after 
transplantation only in the kidney recipients 
with normal kidney function, but returned to 
normal in patients with DGF on the 3rd day 
after transplantation. This cannot be due to 
relative smallness of the DGF group (type 2 
error), regarding the reversed results obtained 
when comparing T3 in the two groups, also this 
fact that in all patients, significantly reduced 
TSH serum level in those who had received no 
ATG continued to the end of the third week, 
while in ATG-administered ones returned to 
the pretransplantation level after 1 week. We 
hypothesize this may be a falsely elevated level 
due to ATG administration and the presence of 
antimouse or antihorse antibodies in the serum 
of these patients results in falsely elevated TSH 
values when using radioimmunoassay method 
for TSH measurement. Indeed, 4 patients in 
the DGF group had received ATG. The same 
reason for falsely elevated TSH serum level in 
transplanted patients was proposed by Seghers and 
colleagues. (11) We were not able to repeat the TSH 
determination in the presence of normal horse 
serum and obtain a true TSH value. Fractionation 
of the serum with protein-A chromatography, 
to detect the falsely elevated TSH measured by 
immunoreactivity, was not performed either.(11)
CONCLUSION
Both T3 and T4 levels decreased early after 
kidney transplantation. When considering the 
effect of DGF on thyroid hormones changes, 
T3 and T4 significantly reduced in patients 
with DGF compared with normal-functioning 
kidney transplant group. This significantly 
greater reduction in T3 and T4 in the DGF 
group, despite no significant difference between 
the two groups before transplantation, is more 
compatible with a consequence rather than 
a cause of DGF occurrence, explained in the 
setting of SES. Continuation of the reduction 
in TSH level in patients with normal kidney 
function early after transplantation until the end 
of the 3rd week in spite of its return to normal 
level in DGF-inflicted patients can be ascribed a 
falsely elevated level due to ATG administration 
and the presence of antimouse or antihorse 
antibodies in the serum of these patients with 
DGF, resulting in falsely elevated TSH values, 
when using radioimmunoassay method for TSH 
measurement.
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